Calcium oxalate kidney stones are a prevalent health concern, affecting approximately 5 to 15% of individuals in the United States during their lifetime. These stones form when oxalate—a natural compound found in many foods—binds with calcium in the urine, leading to crystallization and stone development. A unique anaerobic bacterium, Oxalobacter formigenes, has garnered attention for its specialized role in degrading dietary oxalate, thereby potentially reducing urinary oxalate levels and the associated risk of kidney stone formation.
Fig.1 O. formigenes and hyperoxaluria.1
O. formigenes is a Gram-negative, obligate anaerobic bacterium uniquely specialized in oxalate metabolism. Unlike other gut microbiota, its survival hinges exclusively on oxalate as a carbon and energy source. The bacterium utilizes an extraordinary enzymatic pathway involving oxalyl-CoA decarboxylase and formyl-CoA transferase. Together, these enzymes convert harmful dietary oxalate efficiently into harmless byproducts—formate and carbon dioxide—thereby significantly decreasing the intestinal absorption of oxalate and subsequent urinary excretion.
By degrading oxalate in the intestinal tract, O. formigenes reduces the amount available for absorption into the bloodstream. This process leads to lower urinary oxalate levels, diminishing the likelihood of calcium oxalate supersaturation—a primary driver of stone formation. Additionally, O. formigenes may stimulate intestinal oxalate secretion, further decreasing systemic oxalate levels.
Get a quote Now →
Studies have demonstrated a significant inverse relationship between O. formigenes colonization and kidney stone risk. In a case-control study, only 17% of recurrent calcium oxalate stone formers were colonized with O. formigenes, compared to 38% of control subjects. This colonization was associated with a 70% reduction in the risk of recurrent stones.1 Factors such as antibiotic use, particularly quinolones, can deplete O. formigenes populations, thereby increasing stone risk.
Populations naturally colonized by O. formigenes consistently demonstrate substantially lower urinary oxalate levels and a diminished incidence of kidney stones. This biological evidence underscores the bacterium's role as a crucial preventative measure, reducing both initial stone formation and recurrence. Sustaining healthy populations of O. formigenes, therefore, emerges as a significant preventive strategy against kidney stones.
Diets high in oxalate-rich foods—such as spinach, nuts, and certain berries—without adequate calcium intake can increase oxalate absorption. Low-fiber diets may also impair gut microbiome diversity, adversely affecting O. formigenes colonization.
The overuse of antibiotics, especially those targeting anaerobic bacteria, can disrupt gut flora and deplete O. formigenes populations. Gastrointestinal surgeries, such as bowel resections, can alter gut ecology, further impacting these beneficial bacteria.
Gradually reducing dietary oxalate intake can prevent sudden increases in oxalate excretion, known as "oxalate dumping," which may be detrimental to kidney health.
Developing live anaerobic probiotics containing O. formigenes presents challenges, including ensuring bacterial viability and effective delivery to the gut. Strains like Oxalobacter aliiformigenes and Oxalobacter paraformigenes have shown potential efficacy in degrading oxalate. However, analyses of commercial supplements have revealed inconsistencies; some products lack viable O. formigenes or oxalate-degrading organisms, underscoring the need for rigorous quality control.
Human trials have indicated that O. formigenes supplementation can reduce urinary oxalate levels in individuals prone to stone formation. Additionally, combining O. formigenes with other oxalate-degrading probiotics, such as Lactobacillus acidophilus, may enhance oxalate metabolism.
Probiotic supplementation may benefit individuals who have recently undergone antibiotic treatment, those with recurrent kidney stones, or individuals with genetic conditions leading to hyperoxaluria. Consultation with healthcare providers is essential to tailor interventions appropriately.
Contact us now to inquiry our
Personalized microbiome therapies, tailored specifically to individual gut ecology profiles, hold tremendous promise for precise, targeted interventions. Advanced genetic engineering methods, including
CRISPR gene-editing technologies, could significantly enhance the robustness, survival, and effectiveness of O. formigenes probiotic supplements.
Long-term studies examining colonization stability, patient compliance, and kidney stone recurrence rates remain crucial next steps, providing empirical data for broad clinical implementation.
O. formigenes plays a pivotal role in maintaining oxalate balance and reducing the risk of calcium oxalate kidney stones. Preserving its colonization through mindful antibiotic use and dietary choices, alongside exploring probiotic interventions, offers promising avenues for kidney stone prevention. Ongoing research and personalized microbiome approaches are essential to fully harness the benefits of this unique bacterium.
Creative Biolabs provides a comprehensive suite of analytical and developmental services tailored specifically to support the research, formulation, and optimization of O. formigenes probiotics, including but not limited to:
O. formigenes coexists with other gut microbes, potentially influencing overall microbial community structures and functions related to oxalate degradation.
Yes, other gut bacteria can degrade oxalate, but O. formigenes is uniquely efficient, making it a focal point in oxalate metabolism studies.
References
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.